99 related articles for article (PubMed ID: 3539823)
1. Unsuitability of monoclonal antibodies to oncogene proteins for anti-tumour drug-targeting.
Embleton MJ; Habib NA; Garnett MC; Wood C
Int J Cancer; 1986 Dec; 38(6):821-7. PubMed ID: 3539823
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies for radioimmunodetection of tumours and for targeting.
Baldwin RW; Embleton MJ; Pimm MV
Bull Cancer; 1983; 70(2):132-6. PubMed ID: 6575842
[TBL] [Abstract][Full Text] [Related]
3. Preparation and properties of a drug-carrier-antibody conjugate showing selective antibody-directed cytotoxicity in vitro.
Garnett MC; Embleton MJ; Jacobs E; Baldwin RW
Int J Cancer; 1983 May; 31(5):661-70. PubMed ID: 6852982
[TBL] [Abstract][Full Text] [Related]
4. Conjugates of monoclonal antibody 791T/36 with methotrexate in cancer therapy.
Baldwin RW; Embleton MJ; Garnett MC; Pimm MV
NCI Monogr; 1987; (3):95-9. PubMed ID: 3469528
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugates.
Durrant LG; Garnett MC; Gallego J; Armitage NC; Ballantyne KC; Marksman RA; Hardcastle JD; Baldwin RW
Br J Cancer; 1987 Dec; 56(6):722-6. PubMed ID: 3435698
[TBL] [Abstract][Full Text] [Related]
6. Specific in vitro anti-tumour activity of methotrexate-monoclonal antibody conjugates prepared using human serum albumin as an intermediary.
Pietersz GA; Cunningham Z; McKenzie IF
Immunol Cell Biol; 1988 Feb; 66 ( Pt 1)():43-9. PubMed ID: 3372005
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody targeting of methotrexate (MTX) against MTX-resistant tumour cell lines.
Affleck K; Embleton MJ
Br J Cancer; 1992 Jun; 65(6):838-44. PubMed ID: 1616855
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution of a monoclonal antibody-methotrexate conjugate (791T/36-MTX) in patients with colorectal cancer.
Ballantyne KC; Perkins AC; Pimm MV; Garnett MC; Clegg JA; Armitage NC; Baldwin RW; Hardcastle JD
Int J Cancer Suppl; 1988; 2():103-8. PubMed ID: 3162436
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution and tumour localization of a methotrexate-monoclonal-antibody 791T/36 conjugate in nude mice with human tumour xenografts.
Pimm MV; Clegg JA; Garnett MC; Baldwin RW
Int J Cancer; 1988 Jun; 41(6):886-91. PubMed ID: 3372062
[TBL] [Abstract][Full Text] [Related]
10. Preparation of four daunomycin-monoclonal antibody 791T/36 conjugates with anti-tumour activity.
Gallego J; Price MR; Baldwin RW
Int J Cancer; 1984 Jun; 33(6):737-44. PubMed ID: 6376376
[TBL] [Abstract][Full Text] [Related]
11. Experience in the preparation and experimental use of immunocytostatics.
Embleton MJ; Pimm MV; Garnett MC; Rowland GF; Simmonds RG; Baldwin RW
Behring Inst Mitt; 1984 May; (74):108-12. PubMed ID: 6591915
[TBL] [Abstract][Full Text] [Related]
12. A bispecific monoclonal antibody against methotrexate and a human tumour associated antigen augments cytotoxicity of methotrexate-carrier conjugate.
Pimm MV; Robins RA; Embleton MJ; Jacobs E; Markham AJ; Charleston A; Baldwin RW
Br J Cancer; 1990 Apr; 61(4):508-13. PubMed ID: 2331436
[TBL] [Abstract][Full Text] [Related]
13. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
[TBL] [Abstract][Full Text] [Related]
14. Differentiation between monoclonal antibody-defined antigens on a human osteogenic sarcoma cell line (791T) and tumor-localizing properties of the anti-791T/36 antibody.
Dawood F; Embleton MJ; Price MR; Pimm MV; Byers VS; Baldwin RW
Braz J Med Biol Res; 1986; 19(2):257-69. PubMed ID: 3470084
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity and selectivity of ricin toxin A chain-monoclonal antibody 791T/36 conjugates against human tumor cell lines.
Embleton MJ; Byers VS; Lee HM; Scannon P; Blackhall NW; Baldwin RW
Cancer Res; 1986 Nov; 46(11):5524-8. PubMed ID: 3489523
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody targeting of anti-cancer agents: Mühlbock memorial lecture.
Baldwin RW
Eur J Cancer Clin Oncol; 1985 Nov; 21(11):1281-5. PubMed ID: 3908118
[No Abstract] [Full Text] [Related]
17. An improved synthesis of a methotrexate-albumin-791T/36 monoclonal antibody conjugate cytotoxic to human osteogenic sarcoma cell lines.
Garnett MC; Baldwin RW
Cancer Res; 1986 May; 46(5):2407-12. PubMed ID: 3457627
[TBL] [Abstract][Full Text] [Related]
18. Antigenicity and drug susceptibility of human osteogenic sarcoma cells "escaping" a cytotoxic methotrexate-albumin-monoclonal antibody conjugate.
Embleton MJ; Garnett MC; Jacobs E; Baldwin RW
Br J Cancer; 1984 May; 49(5):559-65. PubMed ID: 6586198
[TBL] [Abstract][Full Text] [Related]
19. Comparison of monoclonal antibodies 17-1A and 323/A3: the influence of the affinity on tumour uptake and efficacy of radioimmunotherapy in human ovarian cancer xenografts.
Kievit E; Pinedo HM; Schlüper HM; Haisma HJ; Boven E
Br J Cancer; 1996 Feb; 73(4):457-64. PubMed ID: 8595159
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
